Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Thank you for registering! Take a moment to confirm your subscription to Insider Trades Newsletter so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.
Send Confirmation Email
OTCMKTS:LTUS

Lotus Pharmaceuticals (LTUS) Stock Price, News & Analysis

→ He called Apple at $1.49 and now he says: “Buy these 6 AI stocks.” (From InvestorPlace) (Ad)
Free LTUS Stock Alerts
$0.0047
0.00 (0.00%)
(As of 05/17/2024 ET)
Compare
Today's Range
$0.0047
▼
$0.0047
50-Day Range
$0.0040
▼
$0.0075
52-Week Range
$0.0035
▼
$0.0120
Volume
50 shs
Average Volume
14,943 shs
Market Capitalization
$12.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartHeadlines
LTUS stock logo

About Lotus Pharmaceuticals Stock (OTCMKTS:LTUS)

Lotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the People's Republic of China. The company is based in Nashville, Tennessee.

LTUS Stock Price History

LTUS Stock News Headlines

May 11, 2024 | abcnews.go.com
AP PHOTOS: Lotus Lantern Festival draws thousands in Seoul to celebrate upcoming Buddha's birthday
May 7, 2024 | msn.com
MTG Black Lotus Sold for $3 Million
May 6, 2024 | msn.com
Magic: The Gathering Black Lotus sells for record-breaking $3 million
May 4, 2024 | yahoo.com
What Should ‘The White Lotus’ Do Next? We Asked Designers, Somms, Travel Experts and More
May 2, 2024 | finance.yahoo.com
Eupraxia Pharmaceuticals Announces Gastrointestinal Clinical Advisory Board
April 21, 2024 | msn.com
73 Best TV Shows to Binge Watch (April 2024)
April 18, 2024 | yahoo.com
Lotus’s New Electric SUV Is Coming This Year
April 16, 2024 | msn.com
Researchers explore medicinal potential of lotus benzylisoquinoline alkaloids
April 14, 2024 | au.news.yahoo.com
Modi promises India jobs, infrastructure if re-elected
April 14, 2024 | msn.com
India's Modi promises jobs, infrastructure if BJP wins third term
April 12, 2024 | msn.com
Is It a Miracle Drug or the Latest Showroom Sensation?
April 12, 2024 | ca.finance.yahoo.com
Lotus Ventures Inc. (J.CN)
April 10, 2024 | msn.com
And Just Like That, Lotus Is an EV Maker
April 8, 2024 | finance.yahoo.com
NRx Pharmaceuticals (NASDAQ:NRXP) Announces Data-Lock of Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression
April 6, 2024 | msn.com
Long-standing vegan restaurant Blossoming Lotus closes after two decades in Portland
April 4, 2024 | msn.com
Fentanyl kills thousands of Americans. Could plugging a gap in U.S. intelligence save lives?
April 3, 2024 | finance.yahoo.com
Q4 2023 NRX Pharmaceuticals Inc Earnings Call
April 3, 2024 | msn.com
This Swiss Car Company Built A Scuba-Diving Lotus Elise EV
April 2, 2024 | msn.com
Steel Lotus Fitness to raise money for Harrisburg police K9
March 29, 2024 | msn.com
‘1923’ Breakout Brandon Sklenar To Co-Star Opposite Meghann Fahy In Christopher Landon’s ‘Drop’ From Platinum Dunes And Blumhouse
March 24, 2024 | msn.com
‘The White Lotus’ Thailand is next. These hotels do it on a budget.
March 11, 2024 | msn.com
Lotus’s New Electric Flagship: The Emeya Hyper GT Sedan
March 8, 2024 | msn.com
Lotus Emira Finally Cleared For Sale In U.S. After Three Years
February 26, 2024 | msn.com
A former resident of The World cruise ship spent 6 years onboard, says it's not unlike 'The White Lotus'
February 26, 2024 | msn.com
EV maker Lotus Technology begins second week of trading after SPAC debut
See More Headlines

Company Calendar

Today
5/20/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:LTUS
CUSIP
N/A
CIK
N/A
Web
www.lotuspharma.com
Phone
(941) 267-9684
Fax
86-10-6389-9867
Employees
233
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
$12.66 million
Optionable
Not Optionable
Beta
-0.36

Key Executives

  • Dr. Zhong Yi Liu (Age 63)
    Founder, Chairman, Chief Executive Officer and President
    Comp: $180k
  • Ms. Yan Zeng (Age 55)
    Chief Financial Officer and Principal Accounting Officer
  • Dr. Xing Shen (Age 53)
    Vice President of Corporate Development

Key Competitors

View All Competitors

LTUS Stock Analysis - Frequently Asked Questions

How have LTUS shares performed in 2024?

Lotus Pharmaceuticals' stock was trading at $0.0043 on January 1st, 2024. Since then, LTUS shares have increased by 9.9% and is now trading at $0.0047.
View the best growth stocks for 2024 here.

How do I buy shares of Lotus Pharmaceuticals?

Shares of LTUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:LTUS) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners
"The Biggest Drug Ever" Is Coming
Behind the Markets
Exposed: 10 CENT Crypto to Explode May 20th?
True Market Insiders
The 2024 Gold Rush: Unleashing Market Potential
Priority Gold
**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1!
Huge Alerts
Warren Buffett's "mystery stock"
Stansberry Research
This Could be Your “Big Money” AI Moment
InvestorPlace
Digitizing the $11T commodities sector with one tiny stock
Resource Stock Digest
Elon to Transform U.S. Economy?
Porter & Company